MannKind (MNKD) Ticks Higher Despite Reports Affreza Difficult to Obtain
MannKind (NASDAQ: MNKD) shares gained Wednesday, rising over 5%. Earlier its inhaled insulin ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
